Brelovitug
Gecertificeerd

Brelovitug

Catalog #: HY-P991674
Maat: 1 Each

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100

Technische Specificaties

Description

Brelovitug (BJT-778) is a humanized IgG1 neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg) . Brelovitug has significant antiviral activity, and neutralizes and removes HBV and HDV as well as depleting HBsAg-containing subviral particles. Brelovitug can be used for HDV and HBV infections, chronic hepatitis delta (CHD) and chronic hepatitis B (CHB) research[1][2].

CAS Number

3033337-14-0

Product Name Alternative

BJT-778

UNSPSC

12352100

Target

HBV

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection; Inflammation/Immunology

References & Citations

[1]Lampertico P, et al. Antiviral therapy for chronic hepatitis delta: new insights from clinical trials and real-life studies. Gut. 2025 Apr 7;74 (5) :853-862. |[2]Ramos H J, et al. Characterization of BJT-778, an anti-HBsAg neutralizing monoclonal antibody for treatment of hepatitis B virus and hepatitis D virus infections[C]//EASL Congress. 2024: 5-8.

Shipping Conditions

Room temperature

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-P991674/

Scientific Category

Inhibitory Antibodies

Clinical Information

No Development Reported

Beschrijving

Brelovitug (BJT-778) is a humanized IgG1 neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg) . Brelovitug has significant antiviral a

Specificaties

ProductnaamBrelovitug
Categorie
Beschikbare grootte1 Each
CatalogusnummerHY-P991674